Technology You Ingest: Interview with Harry Travis
Harry J. Travis is an accomplished senior executive with over 25 years experience in all aspects of pharmaceutical distribution channel management. He has held senior leadership positions with Baxter Healthcare, Cardinal Health, Accredo/Medco and Aetna. At Aetna, he held the position of vice president of the Aetna Specialty Pharmacy, and Mail Order Pharmacy. This multi-billion dollar business is ranked in the top-five specialty pharmacies in the US. Additionally, Mr. Travis led the development of the first-ever large-scale cross-corporate central fill operation dedicated to specialty pharmaceuticals.
Mr. Travis is a sought after national speaker on trends in specialty pharmacy and medication adherence and a former board member for sPCMA. He holds a BS in pharmacy from the University of Pittsburgh, School of Pharmacy, and an MBA from The Darden School at the University of Virginia.
etectRx™ is a privately held digital health company seeking to advance patient medication adherence and improve medication ingestion tracking technology. etectRx’s flagship product, the ID-Cap System, is an ingestible event marker that is comprised of a gelatin capsule containing a wireless ingestible sensor, which transmits signals to a wearable reader and then to a smartphone-based app and secure cloud-based server to enable reliable tracking of ingestion events.
etectRx submitted a premarket notification (510(k)) application with the U.S. Food and Drug Administration (FDA) for its ID-Cap System as an ingestible event marker in late 2018 and anticipates FDA clearance for marketing in 2019. The ID-Cap System is currently only available for investigational use in IRB-approved clinical studies. To learn more about etectRx, visit https://etectrx.com/.
– Harry Travis Linkedin: https://www.
– etectRx Linkedin: https://www.